211 related articles for article (PubMed ID: 20851471)
1. Anti-Leishmanial activity of homo- and heteroleptic bismuth(III) carboxylates.
Andrews PC; Frank R; Junk PC; Kedzierski L; Kumar I; MacLellan JG
J Inorg Biochem; 2011 Mar; 105(3):454-61. PubMed ID: 20851471
[TBL] [Abstract][Full Text] [Related]
2. Bismuth(III) β-thioxoketonates as antibiotics against Helicobacter pylori and as anti-leishmanial agents.
Andrews PC; Blair VL; Ferrero RL; Junk PC; Kedzierski L; Peiris RM
Dalton Trans; 2014 Jan; 43(3):1279-91. PubMed ID: 24190067
[TBL] [Abstract][Full Text] [Related]
3. Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.
Loh A; Ong YC; Blair VL; Kedzierski L; Andrews PC
J Biol Inorg Chem; 2015 Oct; 20(7):1193-203. PubMed ID: 26411702
[TBL] [Abstract][Full Text] [Related]
4. Stability and toxicity of tris-tolyl bismuth(V) dicarboxylates and their biological activity towards Leishmania major.
Ong YC; Blair VL; Kedzierski L; Tuck KL; Andrews PC
Dalton Trans; 2015 Nov; 44(41):18215-26. PubMed ID: 26425978
[TBL] [Abstract][Full Text] [Related]
5. Structural motifs in phenylbismuth heterocyclic carboxylates--secondary interactions leading to oligomers.
Anjaneyulu O; Maddileti D; Kumara Swamy KC
Dalton Trans; 2012 Jan; 41(3):1004-12. PubMed ID: 22105914
[TBL] [Abstract][Full Text] [Related]
6. Stability and toxicity of heteroleptic organometallic Bi(V) complexes towards Leishmania major.
Ong YC; Blair VL; Kedzierski L; Andrews PC
Dalton Trans; 2014 Sep; 43(34):12904-16. PubMed ID: 25019320
[TBL] [Abstract][Full Text] [Related]
7. Structural influences on the activity of bismuth(III) indole-carboxylato complexes towards Helicobacter pylori and Leishmania.
Pathak A; Blair VL; Ferrero RL; Kedzierski L; Andrews PC
J Inorg Biochem; 2017 Dec; 177():266-275. PubMed ID: 28583712
[TBL] [Abstract][Full Text] [Related]
8. Synthetic and structural comparisons of bismuth(III) carboxylates synthesised under solvent-free and reflux conditions.
Andrews PC; Deacon GB; Junk PC; Kumar I; Silberstein M
Dalton Trans; 2006 Oct; (40):4852-8. PubMed ID: 17033711
[TBL] [Abstract][Full Text] [Related]
9. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
[TBL]